SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-20-006925
Filing Date
2020-10-07
Accepted
2020-10-07 10:00:13
Documents
2
Period of Report
2020-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_100720.htm 6-K 4467
2 PRESS RELEASE exh_1.htm EX-1 16327
  Complete submission text file 0001171843-20-006925.txt   21740
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 201228255
SIC: 2834 Pharmaceutical Preparations